Boiler Room: The Official Stock Market Discussion

CBalla

Superstar
Supporter
Joined
Aug 7, 2019
Messages
4,888
Reputation
332
Daps
14,977

^^^^
the above is an invite to the small (less than 60 brehs) but productive Coli Traders Discord

Since 2020 we’ve had one breh touch 7 figures, a few brehs touch 6 figures, some touched 5, and we’re looking for 10 new guys.

We also discuss and help each other with topics like trades, crypto, rental property, etc.

First come, first serve, if you’re inactive in the chat, rude, or spamming bs dont waste your time :smile:

Only 10 Open Spots left
 

Rickdogg44

RIP Charmander RIP Kobe
Joined
May 1, 2012
Messages
8,567
Reputation
740
Daps
13,234
Reppin
Atlanta

^^^^
the above is an invite to the small (less than 60 brehs) but productive Coli Traders Discord

Since 2020 we’ve had one breh touch 7 figures, a few brehs touch 6 figures, some touched 5, and we’re looking for 10 new guys.

We also discuss and help each other with topics like trades, crypto, rental property, etc.

First come, first serve, if you’re inactive in the chat, rude, or spamming bs dont waste your time :smile:

Only 10 Open Spots left
7 figures :wow:

:birdman:
nas-letsgetit.gif
 

Teal.

Solo Dolo
Supporter
Joined
Jan 17, 2013
Messages
14,772
Reputation
1,776
Daps
22,460
Reppin
Notfit,GA

^^^^
the above is an invite to the small (less than 60 brehs) but productive Coli Traders Discord

Since 2020 we’ve had one breh touch 7 figures, a few brehs touch 6 figures, some touched 5, and we’re looking for 10 new guys.

We also discuss and help each other with topics like trades, crypto, rental property, etc.

First come, first serve, if you’re inactive in the chat, rude, or spamming bs dont waste your time :smile:

Only 10 Open Spots left
Missed it :to:
 

KING WILL

Superstar
Joined
Jun 14, 2018
Messages
8,491
Reputation
1,301
Daps
22,277
Any of yall gonna be fukking with Ark invest Venture fund when it becomes available on Sofi?

Holds some private companies like SpaceX, X and Databricks.

As well as public companies like Tesla, Palantir, and a few gene editing companies.
 

Chrishaune

Veteran
Bushed
Joined
Jun 28, 2012
Messages
36,175
Reputation
2,461
Daps
88,327
Reppin
Huntsville
VYGR

LEXINGTON, Mass., Jan. 02, 2024 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedicated to advancing neurogenetic medicines, today announced a strategic collaboration and capsid license agreement with Novartis Pharma AG, a subsidiary of Novartis AG (NYSE: NVS) to advance potential gene therapies for Huntingtons disease (HD) and spinal muscular atrophy (SMA). Voyager will provide Novartis a target-exclusive license to access Voyagers TRACER capsids and other intellectual property for the respective diseases, and Voyager and Novartis will collaborate to advance a preclinical gene therapy candidate for HD.


We are thrilled to expand our existing relationship with Novartis, a global leader in the gene therapy field, said Alfred W. Sandrock, Jr., M.D., Ph.D., Chief Executive Officer of Voyager. Combining the proven capabilities of Novartis in gene therapy development and commercialization with Voyagers next-generation TRACER capsids and payloads could enable the advancement of important new therapies for patients. In addition, the consideration Voyager will receive from this collaboration will strengthen our balance sheet and extend our runway into mid-2026.


We look forward to broadening our work with Voyager to help bring forward novel, high-impact gene therapies with the potential to improve the lives of patients affected by severe neurologic conditions, said Fiona Marshall, President of Biomedical Research at Novartis. We believe Voyagers TRACER capsids hold promise for enabling next-generation gene therapies for diseases of the central nervous system, aligning well with our deep neuroscience expertise and gene therapy leadership at Novartis.


Novartis previously exercised options to license novel capsids generated from Voyagers TRACER capsid discovery platform for use in gene therapy programs against two undisclosed neurological disease targets.


Collaboration Details and Financial Terms
Under the terms of the agreement, Novartis has agreed to pay Voyager $100 million of consideration up front, including a $20 million purchase of newly issued equity in Voyager. Voyager is eligible to receive up to $1.2 billion in preclinical, development, regulatory and sales milestones, as well as tiered royalties on global net sales of products incorporating Voyagers TRACER capsids. Novartis will obtain target-exclusive access to Voyagers TRACER capsids related to SMA for the duration of the agreement and will be responsible for all development and commercialization. Novartis will also receive worldwide rights to Voyagers AAV gene therapy for HD, leveraging Voyagers TRACER capsids and proprietary payloads. Voyager will be responsible for preclinical advancement and Novartis will be responsible for all clinical development and commercialization for the HD program.


Chestnut Partners served as exclusive financial advisor to Voyager on this transaction.
 

BlaxOps

Pro
Joined
Jul 18, 2015
Messages
986
Reputation
151
Daps
1,423
Reppin
MiYaYo (Carol City)
Mobileye Global shares were diving on Thursday after the autonomous-driving systems company said it expects a 50% fall in revenue in the first quarter of the year. The disappointment is also a blow to its former parent and majority shareholder Intel.

$INTC $MBLY
 
Top